These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception. Palazzo E, Marabese I, de Novellis V, Oliva P, Rossi F, Berrino L, Rossi F, Maione S. Neuropharmacology; 2001 Mar; 40(3):319-26. PubMed ID: 11166324 [Abstract] [Full Text] [Related]
4. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats. Luger TJ, Lorenz IH, Grabner-Weiss C, Hayashi T. Br J Pharmacol; 1995 Mar; 114(5):1097-103. PubMed ID: 7780645 [Abstract] [Full Text] [Related]
5. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors. Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK. J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266 [Abstract] [Full Text] [Related]
6. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Wong CS, Cherng CH, Luk HN, Ho ST, Tung CS. Eur J Pharmacol; 1996 Feb 15; 297(1-2):27-33. PubMed ID: 8851162 [Abstract] [Full Text] [Related]
11. Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil. Chizh BA, Reissmüller E, Schlütz H, Scheede M, Haase G, Englberger W. Neuropharmacology; 2001 Jul 15; 40(2):212-20. PubMed ID: 11114400 [Abstract] [Full Text] [Related]
12. Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra. Sommer C, Schomacher M, Berger C, Kuhnert K, Müller HD, Schwab S, Schäbitz WR. Acta Neuropathol; 2006 Sep 15; 112(3):277-86. PubMed ID: 16871404 [Abstract] [Full Text] [Related]
13. Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. Ates M, Hamza M, Seidel K, Kotalla CE, Ledent C, Gühring H. Eur J Neurosci; 2003 Feb 15; 17(3):597-604. PubMed ID: 12581177 [Abstract] [Full Text] [Related]
14. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM, Wakley AA, Tsutsui KT, Laggart JD. J Pharmacol Exp Ther; 2012 Mar 15; 340(3):787-800. PubMed ID: 22182934 [Abstract] [Full Text] [Related]
16. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. Richardson JD, Aanonsen L, Hargreaves KM. J Neurosci; 1998 Jan 01; 18(1):451-7. PubMed ID: 9412521 [Abstract] [Full Text] [Related]
18. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model. Chung KM, Song DK, Huh SO, Kim YH, Choi MR, Suh HW. Neuropeptides; 2000 Jan 01; 34(3-4):158-66. PubMed ID: 11021975 [Abstract] [Full Text] [Related]
19. Dizocilpine infusion has a different effect in the development of morphine and cocaine sensitization: behavioral and neurochemical aspects. Scheggi S, Mangiavacchi S, Masi F, Gambarana C, Tagliamonte A, De Montis MG. Neuroscience; 2002 Jan 01; 109(2):267-74. PubMed ID: 11801363 [Abstract] [Full Text] [Related]
20. NMDA antagonist modulation of morphine antinociception in female vs. male rats. Craft RM, Lee DA. Pharmacol Biochem Behav; 2005 Apr 01; 80(4):639-49. PubMed ID: 15820534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]